IMMUCELL CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.14 USD | +0.78% |
|
+2.39% | +0.98% |
| 04-09 | Immucell Corporation Reports Unaudited Sales Results for the Three Months and Twelve Months Ended March 31, 2024 | CI |
| 04-02 | ImmuCell Shares Fall After $20 Million Mixed Securities Shelf Filing | MT |
Chart calendar ImmuCell Corporation
48ec3122.h43JuW7Wcu1QaKofN8dAPULGpw-jLN0L1yhisAIF_cY.3-egzQOiG6MxMJotZZIOfAigl1rqR5tO5EYshXJ0r5fI_qX8O6QRhh0-3Q~e66cf76bdb24705dc379dedc65188b26
Upcoming events on ImmuCell Corporation
Past events on ImmuCell Corporation
| 2024-04-09 16:05 | Q1 2024 Sales and Revenue Release |
| 2024-02-28 09:00 | Q4 2023 Earnings Call |
| 2024-02-27 16:05 | Q4 2023 Earnings Release |
| 2024-01-31 | Lytham Partners Investor Select Conference |
| 2024-01-08 16:05 | Q4 2023 Sales and Revenue Release |
| 2023-11-14 09:00 | Q3 2023 Earnings Call |
| 2023-11-13 16:05 | Q3 2023 Earnings Release |
| 2023-10-05 16:05 | Q3 2023 Sales and Revenue Release |
| 2023-08-11 09:00 | Q2 2023 Earnings Call |
| 2023-08-10 16:05 | Q2 2023 Earnings Release |
| 2023-07-11 16:05 | Q2 2023 Sales and Revenue Release |
| 2023-06-15 09:00 | Annual General Meeting |
| 2023-05-12 09:00 | Q1 2023 Earnings Call |
| 2023-05-11 16:05 | Q1 2023 Earnings Release |
| 2023-04-05 16:05 | Q1 2023 Sales and Revenue Release |
| 2023-02-22 09:00 | FY 2022 Earnings Call |
| 2023-02-21 16:05 | FY 2022 Earnings Release |
| 2023-01-09 16:05 | FY 2022 Sales and Revenue Release |
| 2022-11-22 09:00 | Q3 2022 Earnings Call |
| 2022-11-21 16:05 | Q3 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 |
|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 13,7 | 15,3 15,1 1.33% |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -1,38 -1,36 -1.55% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -1,03 -1,77 41.6% |
|
Net income Million USD | Released Forecast Spread | 0,00 | -1,02 -1,75 41.7% |
|
EPS USD | Released Forecast Spread | -0,19 | -0,14 -0,24 41.67% |
| Announcement Date | 18/02/20 | 22/02/21 |
More events
Past sector events for ImmuCell Corporation
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 07:00 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 2024-04-25 02:00 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
- Stock Market
- Equities
- ICCC Stock
- Calendar ImmuCell Corporation
